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Background: Two-dimensional transthoracic echocardiography (2DTTE) remains the first-line diagnostic imaging
tool to assess primary mitral regurgitation although cardiovascular magnetic resonance (CMR) has proven to
establish left ventricular function more accurately and might evaluate mitral regurgitation severity more reliably. We
sought to compare routine evaluation of left ventricular function and mitral regurgitation severity by 2DTTE with
assessment by CMR in moderate to severe primary mitral regurgitation without overt left ventricular dysfunction.
Methods: We prospectively included 38 patients (79% of male, age 57 ± 14 years) with at least moderate primary
mitral regurgitation, a left ventricular ejection fraction ≥60% and a left ventricular end-systolic diameter ≤45 mm.
Patients with evidence of coronary artery disease, arrhythmias or significant concomitant valvular disease were
excluded. All patients were scheduled for 2DTTE and CMR.
Results: Left ventricular end-diastolic and end-systolic volumes were significantly underestimated by 2DTTE in
comparison with CMR, although there was a strong correlation (Pearson r = 0.81, p < 0.00001 and r = 0.7,
p < 0.00001, respectively). Measurement of the regurgitant orifice was similar between 2DTTE PISA method and
planimetry by CMR (47 ± 24 vs. 42 ± 16 mm2, p = 0.12) with a strong correlation between both imaging techniques
(Pearson r = 0.76, p < 0.0001). By contrast, assessment of the regurgitant volume by 2DTTE and by phase contrast
velocity mapping by CMR showed poor agreement.
Conclusions: In moderate to severe primary mitral regurgitation without overt left ventricular dysfunction, 2DTTE
significantly underestimates left ventricular remodelling in comparison to CMR. Measurement of the regurgitant
orifice with planimetry by CMR shows good agreement with the PISA method by 2DTTE and thus may be a
valuable alternative to assess mitral regurgitation severity.
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Careful assessment and follow-up of asymptomatic pa-
tients with moderate to severe primary mitral regurgita-
tion (MR) is mandatory to define the optimal timing for
surgery [1,2]. Echocardiography is recommended as the
first-line imaging modality for diagnosing MR and more* Correspondence: plancellotti@chu.ulg.ac.be
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article, unless otherwise stated.specifically for establishing its aetiology and mechanism,
for quantifying its severity and for evaluating its reper-
cussion on left ventricular (LV) function [3]. Cardiovas-
cular magnetic resonance (CMR) imaging is the method
of choice in patients with inadequate echogenicity [4].
Although there are limited data in primary MR, CMR
has proved to be a more accurate non-invasive tool than
echocardiography to measure LV dimensions [5]. Fur-
thermore, the regurgitant volume (RVol) obtained by
phase contrast velocity mapping by CMR has been re-
cently accepted as an accurate non-invasive parameterd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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regurgitant orifice has also been validated in a small
series of patients and is an attractive new method to as-
sess MR severity [8].
We sought to compare routine evaluation of LV func-
tion and MR severity by two-dimensional transthoracic
echocardiography (2D TTE) and CMR in patients with
asymptomatic moderate to severe primary MR and with-
out overt LV dysfunction.
Methods
Study population
The present study concerned 41 prospectively included
patients in 2 Belgian centres (CHU Sart Tilman Liège
and University of Antwerp Hospital) with at least mod-
erate primary MR (effective regurgitant orifice [ERO] ≥
20 mm2 and/or a RVol ≥ 30 ml) and without overt signs
of LV dysfunction or dilatation (LV ejection fraction
(EF) ≥60% and LV end-systolic diameter ≤45 mm) after in-
formed consent. Patients with poor echogenicity, history
of coronary artery disease, persistent arrhythmias or other
significant concomitant valvular heart disease (> mild mi-
tral/aortic stenosis or regurgitation) were excluded. More-
over, we did not enrol patients with CMR-incompatible
devices or claustrophobia. The ethical committee of the 2
centres approved the study protocol (Ethisch comité Uni-
versitair Ziekenhuis Antwerpen and Comité d'éthique
Hospitalo-Facultaire Universitaire de Liège).
Transthoracic echocardiography
We performed a comprehensive 2D TTE in all patients
using Vivid 7 or Vivid 9 cardiovascular ultrasound systemA B
Figure 1 Measurement of the ejection fraction by 2D TTE and CMR. A
method in the apical four- and two-chamber view. B. The LVEF by CMR wa
volumes in multiple parallel short-axis slices.(GE Healthcare, Little Chalfont, UK). All data obtained
by echocardiography were analyzed off-line with an
EchoPAC workstation (GE Vingmed Ultrasound AS,
Horten, Norway). End-systolic and end-diastolic LV
diameters were measured with M-mode in the para-
sternal long-axis view according to current recommenda-
tions [9] with subsequent calculation of the LVEF by the
Teichholz formula. LV volumes and LVEF were quantified
by modified Simpson’s method in the apical four- and
two-chamber view (Figure 1A). The severity of MR was
assessed as recommended [3]. The ERO was quantified
using the proximal isovelocity surface area (PISA) method
(Figure 2A). RVol was assessed by the PISA method, as
well as by the Doppler volumetric method. Moderate pri-
mary MR was defined as an ERO between 20 mm2 and
40 mm3 and/or a RVol between 30 ml and 60 ml while an
ERO ≥ 40 mm2 and/or a RVol ≥ 60 ml defined severe MR.
Cardiovascular magnetic resonance
CMR imaging was performed using a 1.5-T scanner
(Symphony TIM, Siemens, Erlangen, Germany). Breath-
hold ECG-gated steady-state free precession sequences
in standard long-axis and multiple parallel short-axis
slices were used for the assessment of end-systolic and
end-diastolic LV dimensions and volumes (Figure 1B). LV
stroke volume (end-diastolic LV volume – end-systolic LV
volume) and the LVEF ([end-systolic volume/end-diastolic
volume] × 100) were calculated. In 22 patients of the study
group, we measured the anatomic regurgitant orifice
(ARO) by planimetry of the regurgitant orifice in a
slice parallel to the valvular plane and perpendicular
to the regurgitant jet at mid-systole as previously. The LVEF by 2D TTE was obtained by the modified Simpson’s
s calculated by assessment of end-diastolic and end-systolic LV
A B
ARO
Figure 2 Measurement of the regurgitant orifice by 2D TTE and CMR. A. Acquisition of PISA radius and continuous wave Doppler of the
MR jet allows calculation of the effective regurgitant orifice. The PISA radius is measured at mid-systole using the first aliasing with a reduced
Nyquist limit (15–40 m/s). B. The anatomic regurgitant orifice can be measured by planimetry on a slice parallel to the valvular plane obtained by
cardiovascular magnetic resonance.
Table 1 Baseline characteristics of the study population
Study population (n = 38)
Demographic data
Age (years) 57 ± 14
Gender (M/F) 30/8
BMI (kg/m2) 25 ± 3
Mitral valve analysis
Degenerative MR 35 (92 %)
Rheumatic MR 2 (5 %)
Other ethiology MR (toxic) 1 (3 %)
Central / Eccentric jets 19 (50 %) / 19 (50 %)
Grade MR
Moderate MR 21 (55 %)
Severe MR 17 (45 %)
BMI = body mass index; MR =mitral regurgitation.
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grade LV stroke volume was obtained by phase con-
trast velocity mapping at the ascending aorta [6]. CMR
RVol was calculated as the difference between the LV
stroke volume and the antegrade LV stroke volume. All
CMR data were assessed by agreement of 2 readers (PJB
and LD) who were blinded to echocardiographic data.
Statistic analysis
All data were analysed with SPSS version 20 (IBM Statis-
tics). Results are expressed as mean ± SD or percentage
unless otherwise specified. Comparisons of LV dimen-
sions, ERO/ARO and RVol obtained by 2D TTE and
CMR were made using the paired Student t test and
Pearson correlation. Bland-Altman analysis was per-
formed and the intraclass correlation coefficient was
calculated to assess the agreement of both imaging
methods. Values of p < 0.05 were considered significant.
Results
All enrolled patients underwent CMR within a period of
1 month after 2DTTE, in 2 patients CMR followed
2DTTE within 2 months but follow-up 2DTTE con-
firmed stable LV dimensions in these patients. 3 patients
had limited image quality on CMR and were excluded
from further analysis. The baseline characteristics of the
remaining study population are summarised in Table 1.
Among the 38 patients included, 79% were males and
the origin of MR was predominantly degenerative (92%).
Severe MR, as assessed by the PISA method, was found
in 45% of patients.
Comparison of measurement by 2D TTE and CMR re-
garding LV dimensions and parameters of MR severity
are represented in Table 2. Measurements of linearLV dimensions by both imaging modalities were statisti-
cally similar (LV end-diastolic dimension: 53 ± 6 mm by
transthoracic echocardiography vs. 53 ± 8 mm by CMR,
p = 0.91; average bias −0.1 mm, 95% confidence inter-
val −8.9 to +8.7 mm and LV end-systolic dimension:
36 ± 5 mm vs. 36 ± 6 mm, p = 0.95; average bias 0 mm,
95% confidence interval −5.7 to +5.7 mm). LV volumes
were overall significantly underestimated by modified
Simpson’s method in comparison with CMR, although LV
end-diastolic and end-systolic volumes showed a strong
correlation by Pearson correlation analysis (Figure 3A
and C). Bland-Altman analysis confirmed general under-
estimation by 2D TTE of both LV end-diastolic volume
(average bias +28 ml, 95% confidence interval −53
to +109 ml) and LV end-systolic volume (average bias
+20 ml, 95% confidence interval −25 to + 66 ml) (Figure 3B
Table 2 Comparison of 2D TTE and CMR measurements of LV dimensions and MR severity
2D TTE CMR Pearson correlation
LVEDD (mm) 53 ± 6 53 ± 8 p = 0.9 r = 0.80 p < 0.00001
LVESD (mm) 36 ± 5 36 ± 6 p = 1 r = 0.85 p < 0.00001
LVEF (%) teichholz 64 ± 8 61 ± 7 p = 0.05 r = 0.26 p = 0.1
LVEDV (ml) 136 ± 52 164 ± 70 p = 0.0003 r = 0.81 p < 0.00001
LVESV (ml) 44 ± 16 65 ± 31 p < 0.00001 r = 0.7 p < 0.00001
LVSV (ml) 90 ± 39 99 ± 46 p = 0.06 r = 0.75 p < 0.00001
LVEF (%) simpson 67 ± 5 61 ± 7 p = 0.0004 r = 0.27 p = 0.1
ERO/ARO (mm2) 48 ± 25 42 ± 17 p = 0.1 r = 0.76 p < 0.0001
RVol (ml) pisa 69 ± 38 39 ± 27 p = 0.001 r = 0.38 p = 0.07
RVol (ml) doppler volumetric method 67 ± 33 28 ± 16 p = 0.003 r = −0.15 p = 0.6
MR = mitral regurgitation; LVEDD = left ventricular end-diastolic diameter; LVESD = left ventricular end-systolic volume; LVEF = left ventricular ejection fraction;
LVEDV = left ventricular end-diastolic volume; LVESV = left ventricular end-systolic volume; LVSV = left ventricular stroke volume; ERO = effective regurgitant
orifice; ARO = anatomical regurgitant orifice; RVol = regurgitant volume.
Figure 3 Comparison of measurements of LV end-diastolic and end-systolic volumes by 2D TTE and CMR. A. Measurement of LV end-
diastolic volumes by both imaging methods showed a strong correlation by Pearson correlation analysis (r = 0.81, p < 0.00001). B. Bland-Altman
analysis indicated general underestimation of the LV end-diastolic volume by 2D TTE in comparison with CMR (average bias +28 ml, 95%
confidence interval −53 to +109 ml). C. Measurement of LV end-systolic volumes by both imaging methods showed as well a good correlation
(Pearson r = 0.7, p < 0.00001). D. Bland-Altman analysis revealed general underestimation of the LV end-systolic volume by 2D TTE compared to
CMR (average bias +20 ml, 95 % confidence interval −25 to +66 ml).
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TTE in comparison with CMR and there was no significant
correlation between LVEF measurements of the two
imaging modalities.
Measurement of the ARO was feasible in 21 out of 22
patients (95%). ERO calculated by the PISA method with
2D TTE was similar to ARO measured by planimetry
with CMR (47 ± 24 vs. 42 ± 16 mm2, p = 0.12). Pearson
correlation analysis showed a strong correlation bet-
ween both imaging techniques of the regurgitant orifice
(r = 0.76, p < 0.0001) (Figure 4A). Furthermore Bland-
Altman analysis showed good agreement between 2D
TTE PISA method and CMR planimetry of the ARO
(average bias −5.7 mm2, 95% confidence interval −37
to +26 mm2), less accordance was observed in some pa-
tients with an ERO ≥50 mm2 (Figure 4B). In addition,
the intraclass correlation coefficient (=0.7, p = 0.0001)
confirmed strong agreement between both methods to
quantify the regurgitant orifice. By contrast, RVol cal-
culated by either of the two 2D TTE methods was signi-
ficantly higher in comparison with RVol obtained by
phase contrast velocity mapping by CMR (PISA method
vs. CMR: 69 ± 38 vs. 39 ± 27 ml, p = 0.001; r = 0.45,
p = 0.07; Doppler volumetric method vs. CMR: 67 ± 33
vs. 28 ± 16 ml, p = 0.003; r = −0.14, p = 0.6). Assessment
of regurgitant volume by PISA and Doppler volumetric
method by 2D TTE was similar (74 ± 40 vs. 67 ± 33 ml,
p = 0.6). Of note, 20% of patients with moderate MR ac-
cording to ERO as assessed by the PISA method were
reclassified as severe MR according to planimetry of
ARO, likewise 20% of patients with severe MR by 2D
TTE were reclassified as moderate MR by CMR.Figure 4 Comparison of ERO measured by 2D TTE and ARO measured
between 2D TTE PISA method and CMR planimetry of the ARO (r = 0.76, p
both imaging techniques of the regurgitant orifice (average bias −5.7 mm2
observed in some patients with an ERO ≥50 mm².Discussion
LV dimensions and volumes
An important finding of the present study is that LV
volumes are significantly underestimated by 2D TTE in
patients with moderate to severe primary MR in com-
parison with CMR, which is widely accepted as the most
accurate non-invasive imaging tool to assess LV shape
and sizes [10]. This finding might be of importance since
adequate assessment of LV contractility and dimensions
is crucial for clinical decision making in these patients.
It is well known that LV volumes may be significantly
underestimated (even up to 50%) by 2D TTE in com-
parison with invasive ventriculography or CMR in pa-
tients with normal and decreased LV function due to
poor image quality, apical foreshortening and geomet-
rical assumptions [5,11,12]. However, there are poor data
about the degree of underestimation of LV volumes by
2D TTE in patients with primary MR with good echo-
genicity and without overt LV dysfunction; our data
showed a mean difference of 28 ml regarding the LV
end-diastolic volume and 20 ml regarding the LV-end
systolic volume. Interestingly, there was a strong correl-
ation between measurements of LV volumes by the two
imaging methods, which may suggest that 2D TTE may
still be useful to evaluate the progression of LV remodel-
ling in a single patient. At present, guidelines use linear
LV dimensions (LV end-systolic diameter) to define
LV dilatation in primary MR as a criterion for surgery
[4,13]. Our study showed very good agreement be-
tween 2D TTE and CMR regarding the measurement
of linear LV dimensions. However, a recent CMR study
by Schiros et al. [14] showed that the LV end-systolicby CMR. A. Pearson correlation analysis showed a strong correlation
< 0.0001). B. Bland-Altman analysis showed good agreement between
, 95% confidence interval −37 to +26 mm2), less accordance was
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mitral valve leaflet tips may underestimate the LV
volume due to spherical mid to apical remodeling.
Further studies are needed to determine whether
assessment of LV volumes has a benefit over LV linear
dimensions for risk stratification in patients with
asymptomatic primary MR.
LV ejection fraction
Both Teichholz formula and modified Simpson’s method
by 2D TTE seemed to overestimate LVEF in comparison
to CMR. Furthermore, there was no significant correl-
ation between both imaging modalities regarding quanti-
fication of the LVEF. However, our study population
consisted of subjects with a preserved LV function and,
as a consequence, a narrow range of LVEF (60-75%).
Furthermore, 2D TTE is known to have a higher inter-
observer variability than CMR, with a mean percentage
of error that can be up to 10-15% [12] which implies
that a large number of patients should have been in-
cluded to detect any correlation between the two im-
aging modalities. Of note, 33% of our patients with
severe MR and preserved LV function (LVEF ≥60%) by
2D TTE Simpson’s method had a mild decreased LVEF
(50-59%) by CMR and therefore already have a class I
recommendation for surgery [4,13]. These observations
are in line with another small CMR study in patients
with moderate to severe primary MR [15] and suggest
that more accurate assessment of LVEF by CMR might
be indicated in asymptomatic severe MR to determine
optimal timing for surgery.
Severity of MR
The PISA method with calculation of ERO and RVol is
strongly recommended to assess MR severity [3]. How-
ever, several studies have used RVol obtained by phase
contrast velocity mapping by CMR as a reference me-
thod to compare various 2D and 3D echocardiographic
techniques to evaluate MR severity [6,8,16,17].
To our knowledge, only one study by Buchner et al. in
35 patients with mitral regurgitation described planim-
etry of the ARO and found a good agreement with cal-
culation of the ERO by the PISA method [8]. In their
study, 66% of patients had less than grade III mitral
regurgitation, 66% had primary MR and 43% had a
LVEF <50%. Their data showed that ARO was slightly
higher than ERO, presumably because ERO represents
the narrowest flow stream, which is located distal from
the anatomic orifice. Our study confirms good agreement
between the two methods in 21 patients with moder-
ate to severe primary MR without overt LV dysfunc-
tion. We observed a rather higher ERO than ARO for
most ERO values >50 mm2, although this finding has
little clinical implications since most of these caseswere graded as ‘severe’ by both methods. Thus, plan-
imetry of the ARO by CMR seems to be a valuable
alternative in patients with primary MR and poor echo-
genicity or eccentric jets which are difficult to assess with
the PISA method.
In our study, RVol derived from CMR showed only
moderate correlation with RVol obtained by the PISA
method as well as with the Doppler volumetric method.
Furthermore, RVol might have been overestimated by
the PISA method in comparison to CMR, which is in
line with a recent study by Hamada et al. [17]. This
might be due to difficult determination of the - often
dynamic - radius of the hemispheric contour of the flow
convergence zone, especially in eccentric jets. By con-
trast, other studies found rather an underestimation of
RVol by 2D and 3D echocardiographic techniques in
comparison with CMR [18,19], indicating that in any
case measurements of RVol by CMR or by 2D TTE are
not interchangeable.
Limitations
We did not perform more advanced echocardiographic
techniques like 3D or contrast enhanced echocardiog-
raphy, which are known to correlate better with CMR
regarding LV volumes, LVEF and RVol [12,17-20] than
2D TTE. However, notwithstanding the well known
benefits of these techniques, 2D TTE remains the
most widely used imaging method in daily practice
for the assessment of patients with primary MR. Fur-
thermore, there was no comparison with invasive
measurements of LV function or MR severity by an-
giography, but this latter approach is not any more
recommended.
In most patients 2DTTE and CMR were not per-
formed on the same date but within 1 month, which
might influence the measurement of load-dependent
parameters, in particular end-diastolic dimensions. How-
ever, we did not include patients with clinical or echo-
cardiographic signs of heart failure and there were no
patients with acute onset of symptoms during the study
period. Furthermore, underestimation of LV volumes on
2DTTE was also seen in patients in whom both exams
were performed on the same date.
Conclusion
In moderate to severe primary MR without overt LV
dysfunction, 2D TTE seems to significantly underesti-
mate LV remodelling and overestimate LVEF in com-
parison to CMR. These findings might provide more
evidence for routine assessment of LV size and function
by CMR in asymptomatic primary MR in order to better
define optimal timing for surgery. However, further
studies are needed to determine whether the increase in
LV volume is a more powerful predictor of the outcome
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ment of the regurgitant orifice with planimetry by CMR
shows very good agreement with the validated PISA
method by 2D TTE and thus may be a valuable alterna-
tive in patients with poor echogenicity or barely assess-
able eccentric jets.
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